Evaluating techniques of myocardial preservation for aortic valve replacement: Operative risk

Transcatheter Aortic Valve Replacement: A Review Article

Transcatheter aortic valve replacement (TAVR) is a novel therapeutic intervention for the replacement of severely stenotic aortic valves in high-risk patients for standard surgical procedures. Since the initial PARTNER trial results, use of TAVR has been on the rise each year. New delivery methods and different valves have been developed and modified in order to promote the minimally invasive p...

Editorial: Aortic Valve Replacement Without Myocardial Revascularization

BONOW AND COLLEAGUES,' in the preceding paper, concluded that coronary artery bypass grafting (CABG) at the time of aortic valve replacement (AVR) is not advantageous as a near-routine procedure for patients with combined important aortic valve and coronary artery disease. We believe that such a conclusion is premature and unwarranted. The information that is required for making a reliable stat...

Aortic valve replacement with combined myocardial revascularisation.

Early and late outcome was studied in 630 patients who underwent aortic valve replacement between 1974 and 1982. Group 1 (506 patients) did not have important coronary artery disease, group 2 (69 patients) had coronary artery disease and underwent coronary artery bypass grafting, and group 3 (55 patients) had coronary artery disease but did not undergo myocardial revascularisation. Early mortal...

Perioperative risk of redo aortic valve replacement.

BACKGROUND To evaluate the perioperative risk of redo aortic valve replacement (AVR). MATERIALS AND METHODS Sixty-three patients (53 males, 10 females) underwent redo AVR from 2001-2005. Forty-one bioprostheses had to be replaced for degeneration and/or paravalvular leakage, and 18 mechanical prostheses were changed because of thrombosis and/or paravalvular leakage. Four patients with a bicus...

Minimalist Approach to Evaluating Patients for Transcatheter Aortic Valve Replacement.